Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

SITagliptin-simvastatin

SITagliptin-simvastatin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Juvisync TABLET, ORAL 100 mg-10 mg, 100 mg-20 mg, 100 mg-40 mg    
VIEW MORE HMG-CoA Reductase Inhibitors, Dipeptidyl Peptidase IV (DDP-4) Inhibitors
CLASS
240608, 682005
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

SITagliptin-simvastatin (Juvisync)

  • 100 mg-10 mg tablet oral                                                                                    
  • 100 mg-20 mg tablet oral                                                                                                      
  • 100 mg-40 mg tablet oral

SITagliptin (Januvia) AND pravastatin (Pravachol)

  • ONE 100 mg SITagliptin PLUS ONE 20 mg pravastatin
  • ONE 100 mg SITagliptin PLUS ONE 40 mg pravastatin
  • ONE 100 mg SITagliptin PLUS ONE 80 mg pravastatin

IF 'NO SUB':

SITagliptin (Januvia) AND simvastatin (Zocor)

  • ONE 100 mg SITagliptin PLUS ONE 10 mg simvastatin
  • ONE 100 mg SITagliptin PLUS ONE 20 mg simvastatin
  • ONE 100 mg SITagliptin PLUS ONE 40 mg simvastatin

Juvisync medication guide

JUVISYNC is classified as non-formulary, not stocked. Interchange to individual components dispensed separately (simvastatin component is interchanged to pravastatin).

Reviewed: October 25, 2011

Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved